tert-Butyl 2-(4-bromo-1H-imidazol-1-yl)acetate

Catalog No. :
ACGUFE687
CAS No. :
877399-17-2
Molecular Formula :
C9H13BrN2O2
Molecular Weight :
261.12

IUPAC Name:tert-butyl 2-(4-bromo-1H-imidazol-1-yl)acetate

tert-Butyl 2-(4-bromo-1H-imidazol-1-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$101.00Login to see priceIn stockInquiry
5g95%$440.00Login to see priceIn stockInquiry
10g95%$770.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-(4-bromo-1H-imidazol-1-yl)acetate
IUPAC Nametert-butyl 2-(4-bromo-1H-imidazol-1-yl)acetate
MDL No.MFCD18909467
Molecular FormulaC9H13BrN2O2
Molecular Weight261.12
SMILESO=C(OC(C)(C)C)CN1C=C(Br)N=C1
InChI KeyCXYHBBPAZCTFSQ-UHFFFAOYSA-N
Synonym(4-BroMo-iMidazol-1-yl)-acetic acid tert-butyl ester;tert-Butyl 2-(4-broMo-1H-iMidazol-1-yl)acetate;tert-butyl 2-(4-bromoimidazol-1-yl)acetate;1H-Imidazole-1-acetic acid, 4-bromo-, 1,1-dimethylethyl ester
CAS No.877399-17-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGUFE687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGUFE687 route product structure diagram
    ACGUFE687877399-17-2 In Stock
Inquiry

2. ACGUFE687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGUFE687 route product structure diagram
    ACGUFE687877399-17-2 In Stock
Inquiry

Comments (0)